- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
NEW YORK ( TheStreet) -- Pharmacyclics Incorporated (Nasdaq: PCYC) hit a new 52-week high Wednesday as it is currently trading at $96.44, above its previous 52-week high of $95.85 with 431,164 shares traded as of 9:46 a.m. ET. Average volume has been 814,400 shares over the past 30 days. Pharmacyclics has a market cap of $6.32 billion and is part of the health care sector and drugs industry. Shares are up 50.2% year to date as of the close of trading on Tuesday. Pharmacyclics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of small-molecule drugs for the treatment of cancer and immune mediated diseases.